As reported in the 22nd Mar newsletter, Israel’s Pluristem is developing a treatment for severe coronavirus patients.  Latest news is that Pluristem has begun human testing in Israel.

https://www.jpost.com/health-science/israels-company-uses-placenta-cells-to-treat-critical-covid-19-patients-622960